RUNX2 and chronic kidney disease: Together, these data add to the growing body of evidence that CKD is associated with arterial osteogenic phenotypic transformation, and the marked inhibition of DMP–1 expression and lowering of Runx2 by R568 in arterial explants support a role for calcimimetics in preventing arterial calcification.